This topic contains a solution. Click here to go to the answer

Author Question: When an oral drug that is not absorbed systemically is prescribed to a woman who is breastfeeding, ... (Read 60 times)

SGallaher96

  • Hero Member
  • *****
  • Posts: 509
When an oral drug that is not absorbed systemically is prescribed to a woman who is breastfeeding, what is the risk for harm to the infant?
 
  a. Not predicted to increase risk
  b. Low likelihood of increasing the risk
  c. Moderate likelihood of increasing the risk
  d. High likelihood of increasing the risk

Question 2

An elderly patient with a new diagnosis of
 
  hypertension will be receiving a new prescription for an antihypertensive drug. The nurse expects which type of dosing to occur with this drug thera-py?
  a. Drug therapy will be based on the pa-tient's weight.
  b. Drug therapy will be based on the pa-tient's age.
  c. The patient will receive the maximum dose that is expected to reduce the blood pressure.
  d. The patient will receive the lowest possible dose at first, and then the dose will be increased as needed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leeeep

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

ANS: A

Answer to Question 2

ANS: D





 

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library